We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




DSL Acquires Oxford Bio-Innovation

By HospiMedica staff writers
Posted on 12 Nov 2001
In a move that will complement its line of fertility products, Diagnostic Systems Laboratories (DSL; Webster, TX, USA) has acquired Oxford Bio-Innovation Ltd. More...
(OBI, Oxford, UK). Terms were not disclosed.

OBI makes and markets diagnostic and research products and has a clinical testing service. Its products include kits and reagents for inhibin A, inhibin B, and activin, all of which play a role in male infertility, assessment of ovarian reserve, prediction of in vitro fertilization (IVF) outcomes, and differential diagnosis of ovarian cancer. The tests are used by clinical and research laboratories worldwide.

DSL develops and manufactures products for global clinical, research, academic, and veterinary markets and currently offers more than 190 immunoassay products. These include tests for fertility and reproduction, thyroid function, growth factors, and bone and mineral metabolism.

"The acquisition of OBI positions DSL as the exclusive global provider of diagnostic tests for the measurement of inhibins and activins,” said Gopal V. Savjani, CEO of DSL.
"DSL's strength in the field of reproductive endocrinology combined with OBI's focus and experience in the area of inhibins and activins will enable us to accelerate the development of additional products and clinical applications in this field.”




Related Links:
DSL

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Rapid Sepsis Test
SeptiCyte RAPID
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.